A Hybrid Approach to Continuous Biomanufacturing of Biosimilars
19th January 2023 | 10:00am EST / 7:00am PST / 3:00pm GMT / 4:00pm CET | Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech |WATCH FOR FREE
There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end to end operations are not fully realised yet there are opportunities to use these unit operations in a hybrid mode to increase output, reduce footprint and reduce cost of goods. Data from experiments to show effectiveness of these approaches
Presented by Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech
Over 30 years in the Biotechnology industry. Over that time worked in the manufacturing and development of Vaccines, therapeutic/Diagnostic enzymes, and Mabs. Started career at Welcomes then at Genzyme as before moving to Alvotech where has been for 5 years developing Biosimlers as Director of Drug substance development and Now Vice President of Process Technology and Innovation, responsible for driving new technologies and innovation within Alvotech for development and manufacturing